Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Asp2151
1. 841301-32-4
2. Asp 2151
3. Asp2151
4. Amenamevir [inn]
5. Asp-2151
6. 94x46kw4ae
7. N-(2-((4-(1,2,4-oxadiazol-3-yl)phenyl)amino)-2-oxoethyl)-n-(2,6-dimethylphenyl)tetrahydro-2h-thiopyran-4-carboxamide 1,1-dioxide
8. N-(2,6-dimethylphenyl)-n-[2-[4-(1,2,4-oxadiazol-3-yl)anilino]-2-oxoethyl]-1,1-dioxothiane-4-carboxamide
9. Unii-94x46kw4ae
10. Amenalief (tn)
11. Amenamevir [mi]
12. Amenamevir (jan/inn)
13. Amenamevir [jan]
14. Amenamevir [who-dd]
15. Schembl2238614
16. Chembl4297592
17. Dtxsid101027753
18. Bcp29135
19. Ex-a1700
20. S5552
21. Ccg-269570
22. Cs-8093
23. Db11701
24. Sb19732
25. Ncgc00538163-01
26. Ac-35855
27. Bs-17608
28. Hy-14809
29. D10564
30. D84108
31. Q27271708
32. 2-[n-(2,6-dimethylphenyl)-n-[(tetrahydro-2h-thiopyran 1,1-dioxide)-4-ylcarbonyl]amino]-4'-(1,2,4-oxadiazole-3-yl)acetoanilide
33. N-(2,6-dimethylphenyl)-n-(2-((4-(1,2,4-oxadiazol-3-yl)phenyl)amino)-2-oxoethyl)-1,1-dioxothiane-4-carboxamide
34. N-(2,6-dimethylphenyl)-n-(2-{[4-(1,2,4-oxadiazol-3-yl)phenyl]amino}-2-oxoethyl)tetrahydro-2h-thiopyran-4-carboxamide 1,1-dioxide
35. N-(2,6-dimethylphenyl)-n-[2-[4-(1,2,4-oxadiazol-3-yl)anilino]-2-oxo-ethyl]-1,1-dioxo-thiane-4-carboxamide
Molecular Weight | 482.6 g/mol |
---|---|
Molecular Formula | C24H26N4O5S |
XLogP3 | 2.6 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 6 |
Exact Mass | 482.16239112 g/mol |
Monoisotopic Mass | 482.16239112 g/mol |
Topological Polar Surface Area | 131 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 800 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
J - Antiinfectives for systemic use
J05 - Antivirals for systemic use
J05A - Direct acting antivirals
J05AX - Other antivirals
J05AX26 - Amenamevir
Jinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.
2H-Thiopyran-4-carboxylicacid,tetrahydro-(9CI)
CAS Number : 89489-53-2
End Use API : Amenamevir
About The Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our cor...
1,1-Dioxo-hexahydro-1l6-thiopyran-4-carboxylic aci...
CAS Number : 64096-87-3
End Use API : Amenamevir
About The Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our cor...
4-(1,2,4-oxadiazol-3-yl)Benzenamine
CAS Number : 59908-70-2
End Use API : Amenamevir
About The Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our cor...
1,1-Dioxo-tetrahydrothiopyran-4-carboxylic acid
CAS Number : 64096-87-3
End Use API : Amenamevir
About The Company : Eyougene was incubated in Fudan Chemical and has grown into a leader in the field of chemical research and development, now based in the dynamic Lingang area of...
Regulatory Info :
Registration Country : Japan
Brand Name : Amenalief
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Japan
Market Place
Reply
19 Jan 2022
Reply
17 Nov 2021
ABOUT THIS PAGE
A Amenamevir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amenamevir, including repackagers and relabelers. The FDA regulates Amenamevir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amenamevir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Amenamevir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Amenamevir supplier is an individual or a company that provides Amenamevir active pharmaceutical ingredient (API) or Amenamevir finished formulations upon request. The Amenamevir suppliers may include Amenamevir API manufacturers, exporters, distributors and traders.
click here to find a list of Amenamevir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Amenamevir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amenamevir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amenamevir GMP manufacturer or Amenamevir GMP API supplier for your needs.
A Amenamevir CoA (Certificate of Analysis) is a formal document that attests to Amenamevir's compliance with Amenamevir specifications and serves as a tool for batch-level quality control.
Amenamevir CoA mostly includes findings from lab analyses of a specific batch. For each Amenamevir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amenamevir may be tested according to a variety of international standards, such as European Pharmacopoeia (Amenamevir EP), Amenamevir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amenamevir USP).
LOOKING FOR A SUPPLIER?